Sio Capital Management
Latest statistics and disclosures from Sio Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LH, GMED, GSK, UTHR, CI, and represent 35.02% of Sio Capital Management's stock portfolio.
- Added to shares of these 10 stocks: GMED (+$15M), PFE (+$15M), TFX (+$13M), REGN (+$13M), MDT (+$8.7M), EMBC (+$8.6M), HCSG (+$8.5M), OFIX (+$8.4M), ZBH (+$8.2M), TVTX (+$7.9M).
- Started 17 new stock positions in TVTX, EMBC, BBIO, Harpoon Therapeutics, PFE, PRLD, RVMD, ZBH, PTGX, Karuna Therapeutics Ord. SGHT, REGN, TFX, HCSG, Gracell Biotechnologies, MDT, OFIX.
- Reduced shares in these 10 stocks: SWAV (-$44M), SYK (-$24M), GEHC (-$24M), , CI (-$16M), ALGN (-$12M), , AXNX (-$8.3M), PDCO (-$8.1M), HUM (-$5.8M).
- Sold out of its positions in ALGN, AXNX, FGEN, HUM, ISRG, MED, NKTR, PDCO, SWAV, SYK. VRAYQ.
- Sio Capital Management was a net seller of stock by $-34M.
- Sio Capital Management has $323M in assets under management (AUM), dropping by -17.84%.
- Central Index Key (CIK): 0001482416
Tip: Access up to 7 years of quarterly data
Positions held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 52 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Laboratory Corp Amer Hldgs Com New (LH) | 10.5 | $34M | +18% | 169k | 201.05 |
|
| Globus Med Cl A (GMED) | 7.9 | $26M | +143% | 517k | 49.65 |
|
| GSK Sponsored Adr (GSK) | 5.7 | $19M | +6% | 509k | 36.25 |
|
| United Therapeutics Corporation (UTHR) | 5.7 | $18M | +2% | 82k | 225.87 |
|
| Cigna Corp (CI) | 5.2 | $17M | -48% | 58k | 286.07 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 5.1 | $17M | -59% | 242k | 68.04 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 5.0 | $16M | -17% | 797k | 20.09 |
|
| Pfizer (PFE) | 4.6 | $15M | NEW | 451k | 33.17 |
|
| Organon & Co Common Stock (OGN) | 4.1 | $13M | +89% | 767k | 17.36 |
|
| Teleflex Incorporated (TFX) | 3.9 | $13M | NEW | 65k | 196.41 |
|
| Regeneron Pharmaceuticals (REGN) | 3.9 | $13M | NEW | 15k | 822.96 |
|
| Medtronic SHS (MDT) | 2.7 | $8.7M | NEW | 111k | 78.36 |
|
| Embecta Corp Common Stock (EMBC) | 2.6 | $8.6M | NEW | 568k | 15.05 |
|
| Healthcare Services (HCSG) | 2.6 | $8.5M | NEW | 810k | 10.43 |
|
| Orthofix Medical (OFIX) | 2.6 | $8.4M | NEW | 650k | 12.86 |
|
| Zimmer Holdings (ZBH) | 2.5 | $8.2M | NEW | 73k | 112.22 |
|
| Travere Therapeutics (TVTX) | 2.4 | $7.9M | NEW | 885k | 8.94 |
|
| Viking Therapeutics (VKTX) | 2.0 | $6.6M | +12% | 595k | 11.07 |
|
| Gracell Biotechnologies Sponsored Ads | 1.9 | $6.0M | NEW | 2.1M | 2.88 |
|
| Bridgebio Pharma (BBIO) | 1.8 | $5.9M | NEW | 223k | 26.37 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.5 | $4.9M | -13% | 757k | 6.47 |
|
| Silverback Therapeutics (SPRY) | 1.3 | $4.2M | +103% | 1.1M | 3.78 |
|
| Protagonist Therapeutics (PTGX) | 1.3 | $4.1M | NEW | 248k | 16.68 |
|
| Karuna Therapeutics Ord | 1.3 | $4.1M | NEW | 24k | 169.09 |
|
| Revance Therapeutics (RVNC) | 1.2 | $3.9M | +142% | 343k | 11.47 |
|
| ImmunoGen | 1.1 | $3.7M | -5% | 233k | 15.87 |
|
| Merrimack Pharmaceuticals In Com New (MACK) | 1.1 | $3.6M | 289k | 12.33 |
|
|
| Savara (SVRA) | 1.0 | $3.4M | -11% | 896k | 3.78 |
|
| Arcutis Biotherapeutics (ARQT) | 1.0 | $3.4M | +117% | 636k | 5.31 |
|
| Adc Therapeutics Sa SHS (ADCT) | 0.9 | $3.0M | -18% | 3.3M | 0.90 |
|
| X4 Pharmaceuticals (XFOR) | 0.9 | $2.8M | +48% | 2.6M | 1.09 |
|
| Revolution Medicines (RVMD) | 0.6 | $2.0M | NEW | 73k | 27.68 |
|
| Ideaya Biosciences (IDYA) | 0.6 | $2.0M | 74k | 26.98 |
|
|
| Nyxoah Sa SHS (NYXH) | 0.4 | $1.4M | 200k | 7.05 |
|
|
| Aprea Therapeutics Com New (APRE) | 0.4 | $1.2M | 280k | 4.17 |
|
|
| Prelude Therapeutics (PRLD) | 0.3 | $1.1M | NEW | 350k | 3.09 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.3 | $1.0M | 150k | 6.74 |
|
|
| Repare Therapeutics Ord (RPTX) | 0.3 | $919k | 76k | 12.08 |
|
|
| Sight Sciences (SGHT) | 0.3 | $831k | NEW | 247k | 3.37 |
|
| Modular Med Com New (MODD) | 0.2 | $800k | 689k | 1.16 |
|
|
| Harpoon Therapeutics Com New | 0.2 | $677k | NEW | 168k | 4.03 |
|
| Fusion Pharmaceuticals (FUSN) | 0.2 | $640k | 246k | 2.60 |
|
|
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.1 | $478k | 254k | 1.88 |
|
|
| Vanda Pharmaceuticals (VNDA) | 0.1 | $422k | -4% | 98k | 4.32 |
|
| Inogen (INGN) | 0.1 | $276k | -52% | 53k | 5.22 |
|
| Nextcure (NXTC) | 0.1 | $168k | 130k | 1.29 |
|
|
| Moleculin Biotech | 0.0 | $116k | -10% | 271k | 0.43 |
|
| Vincerx Pharma Com New (VINC) | 0.0 | $103k | 102k | 1.01 |
|
|
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $70k | 400k | 0.17 |
|
|
| Caremax Com Cl A | 0.0 | $65k | 31k | 2.12 |
|
|
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $33k | 50k | 0.67 |
|
|
| Caremax *w Exp 06/08/202 (CMAXW) | 0.0 | $2.4k | 13k | 0.18 |
|
Past Filings by Sio Capital Management
SEC 13F filings are viewable for Sio Capital Management going back to 2010
- Sio Capital Management 2023 Q3 filed Nov. 14, 2023
- Sio Capital Management 2023 Q2 filed Aug. 14, 2023
- Sio Capital Management 2023 Q1 filed May 12, 2023
- Sio Capital Management 2022 Q4 filed Feb. 13, 2023
- Sio Capital Management 2022 Q3 filed Nov. 14, 2022
- Sio Capital Management 2022 Q2 filed Aug. 15, 2022
- Sio Capital Management 2022 Q1 filed May 16, 2022
- Sio Capital Management 2021 Q4 filed Feb. 14, 2022
- Sio Capital Management 2021 Q3 filed Nov. 15, 2021
- Sio Capital Management 2021 Q2 filed Aug. 16, 2021
- Sio Capital Management 2021 Q1 filed May 14, 2021
- Sio Capital Management 2020 Q4 filed Feb. 16, 2021
- Sio Capital Management 2020 Q3 filed Nov. 16, 2020
- Sio Capital Management 2020 Q2 filed Aug. 14, 2020
- Sio Capital Management 2020 Q1 filed May 15, 2020
- Sio Capital Management 2019 Q4 filed Feb. 14, 2020